Literature DB >> 11045923

High-throughput sequencing in the population analysis of bacterial pathogens of humans.

M C Maiden1.   

Abstract

High-throughput nucleotide sequence determination technologies present new opportunities for studies of bacterial pathogens by enabling the accumulation of large volumes of biodiversity information from isolate collections. Population studies, which combine these data with epidemiological, phylogenetic, and evolutionary concepts, provide insights into the behaviour of pathogens that are unavailable from other approaches as they address questions of relevance to pathogenesis from the perspective of the infectious organism rather from that of the host. Hypothesis-driven analyses applied to these data permit the determination of microbial population diversity and structure, the identification of the mechanisms of genetic change in bacterial populations, and the generation of models of pathogen evolution. The nucleotide sequence-based population studies performed to date demonstrate a spectrum of nucleotide sequence diversity, population structure, and evolutionary mechanisms among pathogenic bacteria. The rapid development of nucleotide sequence determination and analysis techniques provides the tools necessary for the prosecution of population studies on an increasing number of bacterial pathogens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045923     DOI: 10.1016/S1438-4221(00)80089-2

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  14 in total

Review 1.  Pyrosequencing: sequence typing at the speed of light.

Authors:  Matthew A Diggle; Stuart C Clarke
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

Review 2.  Molecular techniques for the investigation of meningococcal disease epidemiology.

Authors:  M C Maiden; M Frosch
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

3.  Clonal nature of Campylobacter fetus as defined by multilocus sequence typing.

Authors:  Marcel A P van Bergen; Kate E Dingle; Martin C J Maiden; Diane G Newell; Linda van der Graaf-Van Bloois; Jos P M van Putten; Jaap A Wagenaar
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

4.  Multilocus sequence typing system for Campylobacter jejuni.

Authors:  K E Dingle; F M Colles; D R Wareing; R Ure; A J Fox; F E Bolton; H J Bootsma; R J Willems; R Urwin; M C Maiden
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

5.  Genetic diversity and carriage dynamics of Neisseria lactamica in infants.

Authors:  Julia S Bennett; David T Griffiths; Noel D McCarthy; Karen L Sleeman; Keith A Jolley; Derrick W Crook; Martin C J Maiden
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Deep sequencing of short RNAs reveals novel microRNAs in minor salivary glands of patients with Sjögren's syndrome.

Authors:  M Tandon; A Gallo; S-I Jang; G G Illei; I Alevizos
Journal:  Oral Dis       Date:  2011-09-06       Impact factor: 3.511

7.  Phenotypic and genotypic approaches to characterization of isolates of Neisseria meningitidis from patients and their close family contacts.

Authors:  G Tzanakaki; R Urwin; M Musilek; P Kriz; J Kremastinou; A Pangalis; C C Blackwell; M C Maiden
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

8.  Multilocus sequence typing.

Authors:  Ana Belén Ibarz Pavón; Martin C J Maiden
Journal:  Methods Mol Biol       Date:  2009

9.  Carried meningococci in the Czech Republic: a diverse recombining population.

Authors:  K A Jolley; J Kalmusova; E J Feil; S Gupta; M Musilek; P Kriz; M C Maiden
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

10.  Molecular characterization of Campylobacter jejuni clones: a basis for epidemiologic investigation.

Authors:  Kate E Dingle; Frances M Colles; Roisin Ure; Jaap A Wagenaar; Birgitta Duim; Frederick J Bolton; Andrew J Fox; David R A Wareing; Martin C J Maiden
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.